Healthcare sector | Medical Devices industry
| Price | $8.71 |
|---|---|
| Shares Outstanding | 38.6M |
| All-Time Low | $2.44 |
| 52-Week Low | $5.93 |
| Net Cash / Share | $0 |
|---|---|
| Net Current Assets / Share | $-0.44 |
| Net Tangible Assets / Share | $1.96 |
| Shares Outstanding Ave Change (Annual) | -0.43% |
| Shares Δ YoY | 1.63% |
| Avg CA Burn (Annual %) | 6.12% (as of 2-20-2026) |
| Avg CA Burn (Quarterly %) | 1.68% (as of 2-20-2026) |
| Max Earning Power / Share | $3.25 |
|---|---|
| Adjusted Earning Power |
$0.87
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
2.24%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 32M (as of 2-20-2026) |
| Avg EBITDA (5Q) | 12M (as of 2-20-2026) |
| Avg Net Income (5Y) | 9.2M (as of 2-20-2026) |
| Avg Net Income (5Q) | 3.5M (as of 2-20-2026) |
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 2-20-2026 |
| Consecutive Years Paid | No | 2-20-2026 |
| Pays Dividend | No | 2-20-2026 |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | Yes | 2-20-2026 |
| Net Income Positive | Yes | 2-20-2026 |
| Current Dividend Streak | No | 2-20-2026 |
Pick a metric to view its history table and chart.
Formula: Tangible Book Value / shares from balance statements. Includes 5 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-09-30 | Quarterly | $1.94 | 73.8M ($73,796,000) | 38M (38,017,907) |
| 2025-06-30 | Quarterly | $2.68 | 106M ($105,959,000) | 39.6M (39,605,005) |
| 2025-03-31 | Quarterly | $2.55 | 101M ($100,951,000) | 39.5M (39,523,787) |
| 2024-12-31 | Quarterly | $2.49 | 97.6M ($97,556,000) | 39.1M (39,132,897) |
| 2024-12-31 | Annual | $2.49 | 97.6M ($97,556,000) | 39.1M (39,132,897) |
| 2024-09-30 | Quarterly | $2.34 | 91.1M ($91,090,000) | 38.9M (38,932,247) |
| 2023-12-31 | Annual | $2.17 | 83.6M ($83,563,000) | 38.5M (38,506,161) |
| 2022-12-31 | Annual | $2.55 | 97.1M ($97,094,000) | 38M (38,049,739) |
| 2021-12-31 | Annual | $2.39 | 94.8M ($94,820,000) | 39.6M (39,640,388) |
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2024-12-31 | 224.3M ($224,257,000) |
| 2023-12-31 | 183M ($183,008,000) |
| 2022-12-31 | 138.8M ($138,832,000) |
| 2021-12-31 | 117.1M ($117,062,000) |
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-03-17 | 38,602,631 | +584,724 |
| 2025-11-07 | 38,017,907 | -767,852 |
| 2025-09-17 | 38,785,759 | -41 |
Latest short-interest change: 347,585 shares (1.05% of float) | Days to cover: 1.86
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-03-12 | 347,585 shares | -7,164 | -2.02% |
| 2026-02-27 | 354,749 shares | -16,492 | -4.44% |
| 2026-02-11 | 371,241 shares | +13,046 | +3.64% |
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| No interesting volume events | ||||
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management that provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.